These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 987891)

  • 41. Comparative studies of two oral contraceptives containing DL norgestrel and D norgestrel.
    Koetsawang S; Rimdusit S; Srivanaboon S; Bhiraleus P; Rachawat D
    J Med Assoc Thai; 1973 May; 56(5):314-8. PubMed ID: 4783789
    [No Abstract]   [Full Text] [Related]  

  • 42. Luteinizing hormone and progesterone in women under postcoital contraception with D-norgestrel.
    Garmendia F; Kesserü E; Urdanivia E; Valencia M
    Fertil Steril; 1976 Nov; 27(11):1250-5. PubMed ID: 976495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopharmacological examination of Anteovin.
    Farkas M; Szigethy A; Sas M
    Ther Hung; 1987; 35(1):14-8. PubMed ID: 3438859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma prolactin concentrations in women treated with low dose combination type oral contraceptives and in women using a d-norgestrel-releasing intrauterine device.
    Nilsson CG; Lähteenmäki P
    Ann Clin Res; 1978 Aug; 10(4):242-5. PubMed ID: 707973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary results of the endometrial and ovarian response to luteal phase norgestrel.
    Roland M
    Fertil Steril; 1976 Sep; 27(9):1105-7. PubMed ID: 964403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical evaluation of two biphasic and one triphasic norgestrel/ethinyl estradiol regimens.
    Larrañaga A; Sartoretto JN; Winterhalter M; Navas Filho F
    Int J Fertil; 1978; 23(3):193-9. PubMed ID: 40893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
    Gupta GN
    Am J Obstet Gynecol; 1985 Mar; 151(6):827. PubMed ID: 3976796
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of norethindrone and some other synthetic gestagens upon the peripheral plasma levels of progesterone and estradiol during early, human pregnancy.
    Nygren KG; Johansson ED
    Acta Obstet Gynecol Scand; 1975; 54(1):57-63. PubMed ID: 46683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical experience with implant contraception.
    Coutinho E
    Contraception; 1978 Oct; 18(4):411-27. PubMed ID: 720074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma levels of d-norgestrel and sex hormone binding globulin during oral d-norgestrel medication immediately after delivery and legal abortion.
    Nilsson S; Victor A; Nygren KG
    Contraception; 1977 Jan; 15(1):87-92. PubMed ID: 560284
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of Norgestrel].
    Toldy M; Sklovský A
    Cesk Gynekol; 1972 Sep; 37(7):517-8. PubMed ID: 5077977
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles].
    Lévrier M
    Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of norgestrel and ethinyloestradiol ingestion on serum levels of sex hormones and gonadotrophins in men.
    Kjeld JM; Puah CM; Kaufman B; Loizou S; Vlotides J; Gwee HM; Kahn F; Sood R; Joplin GF
    Clin Endocrinol (Oxf); 1979 Nov; 11(5):497-504. PubMed ID: 519881
    [No Abstract]   [Full Text] [Related]  

  • 55. Contraception with megestrol acetate implants. Megestrol acetate levels in plasma and the influence on the ovarian function.
    Weiner E; Johansson ED
    Contraception; 1976 Jun; 13(6):685-95. PubMed ID: 1277840
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of ethinyl estradiol administration during early follicular phase of the cycle on the gonadotropin levels and ovarian function.
    Tsai CC; Yen SS
    J Clin Endocrinol Metab; 1971 Dec; 33(6):917-23. PubMed ID: 5135633
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of norgestrel and metyrapone on pituitary-adrenal-ovarian function.
    Givens JR; Andersen RN; Ragland JB; Umstot ES
    Obstet Gynecol; 1976 Oct; 48(4):392-6. PubMed ID: 184406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects on blood lipid and androgen levels of two triphasic oral contraceptives.
    Janaud A; Rouffy J; Upmalis D; Dain MP
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():114-6. PubMed ID: 8260968
    [No Abstract]   [Full Text] [Related]  

  • 59. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans.
    Gerhards E; Lachnit U; Gaude R; Schillinger E
    Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity.
    van Kammen E; Thijssen JH; Rademaker B; Schwarz F
    Contraception; 1975 Jan; 11(1):53-9. PubMed ID: 1116360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.